메뉴 건너뛰기




Volumn 272, Issue 1, 2008, Pages 61-69

Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma

Author keywords

Apoptosis; EGFR; ERK1 2; Renal cell carcinoma; Silibinin; Survivin

Indexed keywords

CASPASE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P53; SILIBININ; SURVIVIN;

EID: 53949096956     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.06.033     Document Type: Article
Times cited : (88)

References (44)
  • 1
    • 0344442746 scopus 로고    scopus 로고
    • Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
    • Janzen N.K., Kim H.L., Figlin R.A., and Belldegrun A.S. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol. Clin. North Am. 30 (2003) 843-852
    • (2003) Urol. Clin. North Am. , vol.30 , pp. 843-852
    • Janzen, N.K.1    Kim, H.L.2    Figlin, R.A.3    Belldegrun, A.S.4
  • 3
    • 29044438856 scopus 로고    scopus 로고
    • Interferon-α 2b as medical selection for nephrectomy in patients with synchronous metastatic renal cell carcinoma: a consecutive study
    • Bex A., Kerst M., Mallo H., Meinhardt W., Horenblas S., and de Gast G.C. Interferon-α 2b as medical selection for nephrectomy in patients with synchronous metastatic renal cell carcinoma: a consecutive study. Eur. Urol. 49 (2006) 76-81
    • (2006) Eur. Urol. , vol.49 , pp. 76-81
    • Bex, A.1    Kerst, M.2    Mallo, H.3    Meinhardt, W.4    Horenblas, S.5    de Gast, G.C.6
  • 4
    • 0036304007 scopus 로고    scopus 로고
    • Chemoprevention of bladder cancer
    • Kamat A.M., and Lamm D.L. Chemoprevention of bladder cancer. Urol. Clin. North Am. 29 (2002) 157-168
    • (2002) Urol. Clin. North Am. , vol.29 , pp. 157-168
    • Kamat, A.M.1    Lamm, D.L.2
  • 5
    • 0142166328 scopus 로고    scopus 로고
    • Cancer chemoprevention with dietary phytochemicals
    • Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3 (2003) 768-780
    • (2003) Nat. Rev. Cancer , vol.3 , pp. 768-780
    • Surh, Y.J.1
  • 6
    • 0036670787 scopus 로고    scopus 로고
    • Flavonoid antioxidant silymarin and skin cancer
    • Singh R.P., and Agarwal R. Flavonoid antioxidant silymarin and skin cancer. Antioxid. Redox Signal. 4 (2002) 655-663
    • (2002) Antioxid. Redox Signal. , vol.4 , pp. 655-663
    • Singh, R.P.1    Agarwal, R.2
  • 7
    • 0034859659 scopus 로고    scopus 로고
    • Silymarin: a review of its clinical properties in the management of hepatic disorders
    • Wellington K., and Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. Biodrugs 15 (2001) 465-489
    • (2001) Biodrugs , vol.15 , pp. 465-489
    • Wellington, K.1    Jarvis, B.2
  • 8
    • 0036606413 scopus 로고    scopus 로고
    • Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels
    • Singh R.P., Dhanalakshmi S., Tyagi A.K., Chan D.C., Agarwal C., and Agarwal R. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels. Cancer Res. 62 (2002) 3063-3069
    • (2002) Cancer Res. , vol.62 , pp. 3063-3069
    • Singh, R.P.1    Dhanalakshmi, S.2    Tyagi, A.K.3    Chan, D.C.4    Agarwal, C.5    Agarwal, R.6
  • 9
    • 0030903321 scopus 로고    scopus 로고
    • Protective effects of silymarin against photocarcinogenesis in a mouse skin model
    • Katiyar S.K., Korman N.J., Mukhtar H., and Agarwal R. Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J. Natl. Cancer Inst. 89 (1997) 556-566
    • (1997) J. Natl. Cancer Inst. , vol.89 , pp. 556-566
    • Katiyar, S.K.1    Korman, N.J.2    Mukhtar, H.3    Agarwal, R.4
  • 10
    • 0037057520 scopus 로고    scopus 로고
    • Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats
    • Kohno H., Tanaka T., Kawabata K., Hirose Y., Sugie S., Tsuda H., and Mori H. Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Int. J. Cancer 101 (2002) 461-468
    • (2002) Int. J. Cancer , vol.101 , pp. 461-468
    • Kohno, H.1    Tanaka, T.2    Kawabata, K.3    Hirose, Y.4    Sugie, S.5    Tsuda, H.6    Mori, H.7
  • 11
    • 0344827261 scopus 로고    scopus 로고
    • Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells
    • Agarwal C., Singh R.P., Dhanalakshmi S., Tyagi A.K., Tecklenburg M., Sclafani R.A., and Agarwal R. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22 (2003) 8271-8282
    • (2003) Oncogene , vol.22 , pp. 8271-8282
    • Agarwal, C.1    Singh, R.P.2    Dhanalakshmi, S.3    Tyagi, A.K.4    Tecklenburg, M.5    Sclafani, R.A.6    Agarwal, R.7
  • 12
    • 33746127995 scopus 로고    scopus 로고
    • Molecular targeting therapy for renal cell carcinoma
    • Eto M., and Naito S. Molecular targeting therapy for renal cell carcinoma. Int. J. Clin. Oncol. 11 (2006) 209-213
    • (2006) Int. J. Clin. Oncol. , vol.11 , pp. 209-213
    • Eto, M.1    Naito, S.2
  • 13
    • 33750711391 scopus 로고    scopus 로고
    • Kinase inhibitors in the treatment of renal cell carcinoma
    • Larkin J.M., and Eisen T. Kinase inhibitors in the treatment of renal cell carcinoma. Crit. Rev. Oncol. Hematol. 60 (2006) 216-226
    • (2006) Crit. Rev. Oncol. Hematol. , vol.60 , pp. 216-226
    • Larkin, J.M.1    Eisen, T.2
  • 15
    • 34249909820 scopus 로고    scopus 로고
    • The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation
    • Cohen D., Lane B., Jin T., Magi-Galluzzi C., Finke J., Rini B.I., Bukowski R.M., and Zhou M. The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation. Clin. Genitourin. Cancer 5 (2007) 264-270
    • (2007) Clin. Genitourin. Cancer , vol.5 , pp. 264-270
    • Cohen, D.1    Lane, B.2    Jin, T.3    Magi-Galluzzi, C.4    Finke, J.5    Rini, B.I.6    Bukowski, R.M.7    Zhou, M.8
  • 16
    • 34247156342 scopus 로고    scopus 로고
    • EGFR and VEGFR2 protein expressions in bone metastases of clear cell renal cancer
    • Badalian G., Derecskei K., Szendroi A., Szendroi M., and Timar J. EGFR and VEGFR2 protein expressions in bone metastases of clear cell renal cancer. Anticancer Res. 27 (2007) 889-894
    • (2007) Anticancer Res. , vol.27 , pp. 889-894
    • Badalian, G.1    Derecskei, K.2    Szendroi, A.3    Szendroi, M.4    Timar, J.5
  • 18
    • 28244442462 scopus 로고    scopus 로고
    • Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease
    • Fadeel B., and Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J. Intern. Med. 258 (2005) 479-517
    • (2005) J. Intern. Med. , vol.258 , pp. 479-517
    • Fadeel, B.1    Orrenius, S.2
  • 20
    • 14544282903 scopus 로고    scopus 로고
    • Targeted for destruction: the molecular basis for development of novel therapeutic strategies in renal cell cancer
    • Srinivasan R., and Linehan W.M. Targeted for destruction: the molecular basis for development of novel therapeutic strategies in renal cell cancer. J. Clin. Oncol. 23 (2005) 410-412
    • (2005) J. Clin. Oncol. , vol.23 , pp. 410-412
    • Srinivasan, R.1    Linehan, W.M.2
  • 21
    • 16544375170 scopus 로고    scopus 로고
    • Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by l-buthionine sulfoximine
    • Wu X.X., Ogawa O., and Kakehi Y. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by l-buthionine sulfoximine. Int. J. Oncol. 24 (2004) 1489-1497
    • (2004) Int. J. Oncol. , vol.24 , pp. 1489-1497
    • Wu, X.X.1    Ogawa, O.2    Kakehi, Y.3
  • 22
    • 33745112128 scopus 로고    scopus 로고
    • Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-κB in mouse epidermal JB6 cells
    • Singh R.P., Dhanalakshmi S., Mohan S., Agarwal C., and Agarwal R. Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-κB in mouse epidermal JB6 cells. Mol. Cancer Ther. 5 (2006) 1145-1153
    • (2006) Mol. Cancer Ther. , vol.5 , pp. 1145-1153
    • Singh, R.P.1    Dhanalakshmi, S.2    Mohan, S.3    Agarwal, C.4    Agarwal, R.5
  • 23
    • 0034057320 scopus 로고    scopus 로고
    • Apoptosis in cancer
    • Lowe S.W., and Lin A.W. Apoptosis in cancer. Carcinogenesis 21 (2000) 485-495
    • (2000) Carcinogenesis , vol.21 , pp. 485-495
    • Lowe, S.W.1    Lin, A.W.2
  • 24
    • 0037267333 scopus 로고    scopus 로고
    • Validating survivin as a cancer therapeutic target
    • Altieri D.C. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3 (2003) 46-54
    • (2003) Nat. Rev. Cancer , vol.3 , pp. 46-54
    • Altieri, D.C.1
  • 25
    • 11344256534 scopus 로고    scopus 로고
    • Molecular and cytometric analysis of renal cell carcinoma cells. Concepts, techniques and prospects
    • Li G., Lambert C., Gentil-Perret A., Genin C., and Tostain J. Molecular and cytometric analysis of renal cell carcinoma cells. Concepts, techniques and prospects. Prog. Urol. 13 (2003) 1-13
    • (2003) Prog. Urol. , vol.13 , pp. 1-13
    • Li, G.1    Lambert, C.2    Gentil-Perret, A.3    Genin, C.4    Tostain, J.5
  • 26
    • 0034667455 scopus 로고    scopus 로고
    • Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells
    • Zi X., Zhang J., Agarwal R., and Pollak M. Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells. Cancer Res. 60 (2000) 5617-5620
    • (2000) Cancer Res. , vol.60 , pp. 5617-5620
    • Zi, X.1    Zhang, J.2    Agarwal, R.3    Pollak, M.4
  • 27
    • 0347121831 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line
    • Qi L., Singh R.P., Lu Y., Agarwal R., Harrison G.S., Franzusoff A., and Glode L.M. Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line. Cancer Biol. Ther. 2 (2003) 526-531
    • (2003) Cancer Biol. Ther. , vol.2 , pp. 526-531
    • Qi, L.1    Singh, R.P.2    Lu, Y.3    Agarwal, R.4    Harrison, G.S.5    Franzusoff, A.6    Glode, L.M.7
  • 28
    • 4544287556 scopus 로고    scopus 로고
    • Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages
    • Tyagi A., Agarwal C., Harrison G., Glode L.M., and Agarwal R. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages. Carcinogenesis 25 (2004) 1711-1720
    • (2004) Carcinogenesis , vol.25 , pp. 1711-1720
    • Tyagi, A.1    Agarwal, C.2    Harrison, G.3    Glode, L.M.4    Agarwal, R.5
  • 29
    • 0344495296 scopus 로고    scopus 로고
    • Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells
    • Tyagi A.K., Agarwal C., Singh R.P., Shroyer K.R., Glode L.M., and Agarwal R. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells. Biochem. Biophys. Res. Commun. 312 (2003) 1178-1184
    • (2003) Biochem. Biophys. Res. Commun. , vol.312 , pp. 1178-1184
    • Tyagi, A.K.1    Agarwal, C.2    Singh, R.P.3    Shroyer, K.R.4    Glode, L.M.5    Agarwal, R.6
  • 30
    • 33745002041 scopus 로고    scopus 로고
    • Prostate cancer chemoprevention by silibinin: bench to bedside
    • Singh R.P., and Agarwal R. Prostate cancer chemoprevention by silibinin: bench to bedside. Mol. Carcinog. 45 (2006) 436-442
    • (2006) Mol. Carcinog. , vol.45 , pp. 436-442
    • Singh, R.P.1    Agarwal, R.2
  • 31
    • 33744824356 scopus 로고    scopus 로고
    • Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway
    • Chen P.N., Hsieh Y.S., Chiang C.L., Chiou H.L., Yang S.F., and Chu S.C. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J. Dent. Res. 85 (2006) 220-225
    • (2006) J. Dent. Res. , vol.85 , pp. 220-225
    • Chen, P.N.1    Hsieh, Y.S.2    Chiang, C.L.3    Chiou, H.L.4    Yang, S.F.5    Chu, S.C.6
  • 32
    • 26044455880 scopus 로고    scopus 로고
    • Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways
    • Chen P.N., Hsieh Y.S., Chiou H.L., and Chu S.C. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chem. Biol. Interact. 156 (2005) 141-150
    • (2005) Chem. Biol. Interact. , vol.156 , pp. 141-150
    • Chen, P.N.1    Hsieh, Y.S.2    Chiou, H.L.3    Chu, S.C.4
  • 33
    • 2942672061 scopus 로고    scopus 로고
    • Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells
    • Mohan S., Dhanalakshmi S., Mallikarjuna G.U., Singh R.P., and Agarwal R. Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells. Biochem. Biophys. Res. Commun. 320 (2004) 183-189
    • (2004) Biochem. Biophys. Res. Commun. , vol.320 , pp. 183-189
    • Mohan, S.1    Dhanalakshmi, S.2    Mallikarjuna, G.U.3    Singh, R.P.4    Agarwal, R.5
  • 34
    • 0036210452 scopus 로고    scopus 로고
    • Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis
    • Singh R.P., Tyagi A.K., Zhao J., and Agarwal R. Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis 23 (2002) 499-510
    • (2002) Carcinogenesis , vol.23 , pp. 499-510
    • Singh, R.P.1    Tyagi, A.K.2    Zhao, J.3    Agarwal, R.4
  • 35
    • 11144222544 scopus 로고    scopus 로고
    • Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor κB-mediated inducible chemoresistance
    • Singh R.P., Mallikarjuna G.U., Sharma G., Dhanalakshmi S., Tyagi A.K., Chan D.C., Agarwal C., and Agarwal R. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor κB-mediated inducible chemoresistance. Clin. Cancer Res. 10 (2004) 8641-8647
    • (2004) Clin. Cancer Res. , vol.10 , pp. 8641-8647
    • Singh, R.P.1    Mallikarjuna, G.U.2    Sharma, G.3    Dhanalakshmi, S.4    Tyagi, A.K.5    Chan, D.C.6    Agarwal, C.7    Agarwal, R.8
  • 36
    • 33846211547 scopus 로고    scopus 로고
    • Silibinin inhibits renal cell carcinoma via mechanisms that are independent of insulin-like growth factor-binding protein 3
    • Cheung C.W., Vesey D.A., Nicol D.L., and Johnson D.W. Silibinin inhibits renal cell carcinoma via mechanisms that are independent of insulin-like growth factor-binding protein 3. BJU Int. 99 (2007) 454-460
    • (2007) BJU Int. , vol.99 , pp. 454-460
    • Cheung, C.W.1    Vesey, D.A.2    Nicol, D.L.3    Johnson, D.W.4
  • 37
    • 34447130474 scopus 로고    scopus 로고
    • Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levels
    • Cheung C.W., Taylor P.J., Kirkpatrick C.M., Vesey D.A., Gobe G.C., Winterford C., Nicol D.L., and Johnson D.W. Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levels. BJU Int. 100 (2007) 438-444
    • (2007) BJU Int. , vol.100 , pp. 438-444
    • Cheung, C.W.1    Taylor, P.J.2    Kirkpatrick, C.M.3    Vesey, D.A.4    Gobe, G.C.5    Winterford, C.6    Nicol, D.L.7    Johnson, D.W.8
  • 38
    • 27644439523 scopus 로고    scopus 로고
    • Mechanisms and preclinical efficacy of silibinin in preventing skin cancer
    • Singh R.P., and Agarwal R. Mechanisms and preclinical efficacy of silibinin in preventing skin cancer. Eur. J. Cancer 41 (2005) 1969-1979
    • (2005) Eur. J. Cancer , vol.41 , pp. 1969-1979
    • Singh, R.P.1    Agarwal, R.2
  • 39
    • 0033571983 scopus 로고    scopus 로고
    • Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties
    • Mahotka C., Wenzel M., Springer E., Gabbert H.E., and Gerharz C.D. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 59 (1999) 6097-6102
    • (1999) Cancer Res. , vol.59 , pp. 6097-6102
    • Mahotka, C.1    Wenzel, M.2    Springer, E.3    Gabbert, H.E.4    Gerharz, C.D.5
  • 40
    • 34548309081 scopus 로고    scopus 로고
    • Prognostic markers in renal cell carcinoma
    • Ljungberg B. Prognostic markers in renal cell carcinoma. Curr. Opin. Urol. 17 (2007) 303-308
    • (2007) Curr. Opin. Urol. , vol.17 , pp. 303-308
    • Ljungberg, B.1
  • 42
    • 33846519318 scopus 로고    scopus 로고
    • Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome
    • Byun S.S., Yeo W.G., Lee S.E., and Lee E. Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome. Urology 69 (2007) 34-37
    • (2007) Urology , vol.69 , pp. 34-37
    • Byun, S.S.1    Yeo, W.G.2    Lee, S.E.3    Lee, E.4
  • 43
    • 34249863881 scopus 로고    scopus 로고
    • Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy
    • Comelli M.C., Mengs U., Schneider C., and Prosdocimi M. Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy. Integr. Cancer Ther. 6 (2007) 120-129
    • (2007) Integr. Cancer Ther. , vol.6 , pp. 120-129
    • Comelli, M.C.1    Mengs, U.2    Schneider, C.3    Prosdocimi, M.4
  • 44
    • 34547829030 scopus 로고    scopus 로고
    • Silibinin inhibits constitutive activation of Stat3 and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells
    • Agarwal C., Tyagi A., Kaur M., and Agarwal R. Silibinin inhibits constitutive activation of Stat3 and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells. Carcinogenesis 28 (2007) 1463-1470
    • (2007) Carcinogenesis , vol.28 , pp. 1463-1470
    • Agarwal, C.1    Tyagi, A.2    Kaur, M.3    Agarwal, R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.